Antitrust: Commission opens formal investigation into Aspen Pharma’s pricing practices for cancer medicines
Commissioner Margrethe Vestager, in charge of competition policy, said: “When we get sick, we may depend on specific drugs to save or prolong our lives. Companies should be rewarded for producing these pharmaceuticals to ensure that they keep making them … read more

